20061299

Source:http://linkedlifedata.com/resource/pubmed/id/20061299

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023787, umls-concept:C0087111, umls-concept:C0205082, umls-concept:C2699007
pubmed:issue	2
pubmed:dateCreated	2010-3-30
pubmed:abstractText	To review evidence supporting the hypothesis that metabolic manifestations of lipodystrophy result from leptin deficiency and that leptin replacement may be a viable treatment for generalized lipodystrophy.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20061299-20350904
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9607439
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Leptin
pubmed:status	MEDLINE
pubmed:issn	1934-2403
pubmed:author	pubmed-author:ChanJean LJL, pubmed-author:OralElif AEA
pubmed:issnType	Electronic
pubmed:volume	16
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	324-33
pubmed:meshHeading	pubmed-meshheading:20061299-Hormone Replacement Therapy, pubmed-meshheading:20061299-Humans, pubmed-meshheading:20061299-Leptin, pubmed-meshheading:20061299-Lipodystrophy
pubmed:articleTitle	Rationale for leptin-replacement therapy for severe lipodystrophy.
pubmed:affiliation	University of Michigan, Ann Arbor, Michigan, USA.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural